HAVN Life Sciences Inc. (OTCMKTS:HAVLF – Get Rating) was the target of a significant growth in short interest in the month of November. As of November 15th, there was short interest totalling 15,100 shares, a growth of 62.4% from the October 31st total of 9,300 shares. Based on an average daily volume of 30,400 shares, the short-interest ratio is currently 0.5 days.
HAVN Life Sciences Trading Up 17.9 %
HAVN Life Sciences stock traded up $0.01 during midday trading on Friday, reaching $0.07. 1,760 shares of the company's stock were exchanged, compared to its average volume of 5,533. HAVN Life Sciences has a 52 week low of $0.05 and a 52 week high of $6.00. The stock's 50-day simple moving average is $0.07 and its 200 day simple moving average is $0.67.
Get HAVN Life Sciences alerts:HAVN Life Sciences Company Profile
(Get Rating)
HAVN Life Sciences Inc, a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The Company also focuses on developing methodologies for the standardize and quality-controlled extraction of psychoactive compounds from plants and fungi, including Psilocybe spp.Featured Articles
- Get a free copy of the StockNews.com research report on HAVN Life Sciences (HAVLF)
- Institutions Are Buying Ambarella, Should You?
- Can ZIM Defy Broad Downturn In The Container Shipping Industry?
- Ford Revving Up Production Of EV Power Units At U.K. Plant
- Are the Short Sellers Still Right About Mullen Automotive stock?
- La-Z-Boy Reclines To More Comfortable Levels
Receive News & Ratings for HAVN Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HAVN Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.